Natixis’s Accendra Health ACH Stock Holding History

Natixis’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-6,132	Closed	-$212K	–	945
2017 Q1	$212K	Buy	+6,132	New	+$219K	﹤0.01%	872

Other funds holding ACH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Natixis's ACH Position: Q2 2017 in Review

Natixis sold out of Accendra Health (ACH) in Q2 2017, closing a stake of 6,132 shares — an estimated $212K sold.

Natixis first reported a position in ACH in Q1 2017 and held it in 1 quarter. The position peaked at $212K in Q1 2017. 273 funds tracked by Wall St. Rank hold ACH as of Q2 2017.

Natixis reported no remaining Accendra Health position as of Q2 2017 after selling out during the quarter.
Natixis sold 6,132 Accendra Health shares in Q2 2017, an estimated $212K.
Natixis first reported a position in Accendra Health in Q1 2017 and held it in 1 quarter.
Natixis's Accendra Health position peaked at $212K in Q1 2017.
273 funds tracked by Wall St. Rank held Accendra Health as of Q2 2017.

Based on Natixis's 13F filing for Q2 2017, filed 14 Aug 2017.